Uric Acid and Chronic Kidney Disease
Srinath Yadlapalli1, Divya K Nekkalapudi2, Jay B Wish1
1Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN.
Insights
Hyperuricemia is common in chronic kidney disease (CKD). Treating symptomatic hyperuricemia is recommended, but evidence for treating asymptomatic cases and its effect on CKD progression is mixed.
Area of Science:
- Nephrology
- Urology
- Metabolic Diseases
Background:
- Hyperuricemia is prevalent in chronic kidney disease (CKD) patients, worsening as kidney function declines.
- The causal link between hyperuricemia and CKD progression is debated.
- Treatment guidelines for symptomatic hyperuricemia in CKD are established, but evidence for treating asymptomatic hyperuricemia is inconsistent.
Purpose of the Study:
- To review uric acid metabolism and its connection to CKD.
- To evaluate the efficacy of uric acid-lowering agents in CKD patients.
- To guide nephrologists in managing hyperuricemia, particularly asymptomatic cases, in CKD.
Main Methods:
- Literature review of studies on uric acid metabolism in CKD.
- Analysis of clinical trials investigating uric acid-lowering therapies.
- Examination of current global society guidelines for hyperuricemia management.
Main Results:
- The association between hyperuricemia and CKD is significant, but causality is uncertain.
- Some studies suggest uric acid-lowering treatment may slow CKD progression, while others show no benefit.
- Discrepancies exist among international guidelines regarding hyperuricemia treatment in CKD.
Conclusions:
- Managing hyperuricemia in CKD requires careful consideration of symptomatic versus asymptomatic cases.
- Choosing appropriate urate-lowering drugs and non-pharmacological therapies is crucial.
- Minimizing medications that elevate uric acid levels is recommended for CKD patients.
Abstract:
The prevalence of hyperuricemia is high among people with chronic kidney disease (CKD), increasing significantly as kidney disease progresses. Whether this is an association or a cause-and-effect relationship remains controversial. While evidence strongly supports the treatment of symptomatic hyperuricemia in people with CKD, the evidence supporting the treatment of asymptomatic hyperuricemia is mixed. Some studies show that treatment retards CKD progression, while others do not. In this review, we discussed uric acid metabolism, its association with CKD, and the use of uric acid-lowering agents. We also examined studies conducted to determine whether treating hyperuricemia is beneficial. We hope to provide nephrologists with the knowledge and confidence to confront hyperuricemia, specifically addressing management of asymptomatic hyperuricemia, the differences among society guidelines worldwide, which urate-lowering drugs should be chosen, the role of non-pharmacological therapy in patients with CKD, and the need to minimize the use of medications that may increase uric acid levels.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Urinary Tract Calculi III: Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
